4D Molecular Therapeutics Inc. (FDMT) Income Statement Analysis - Revenue, Earnings & Profitability Metrics - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    4D Molecular Therapeutics...

    NASDAQ: FDMT · Real-Time Price · USD
    7.27
    0.66 (9.98%)
    At close: Sep 05, 2025, 3:59 PM
    7.36
    1.24%
    After-hours: Sep 05, 2025, 07:25 PM EDT

    4D Molecular Therapeutics Income Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Revenue
    		 37K 20.72M 3.13M 18.04M
    Cost of Revenue
    		 6.71M 97.1M 3.88M 3.02M
    Gross Profit
    		 37K -76.37M -751K 15.02M
    Operating Income
    		 -187.84M -112.87M -110.03M -71.33M
    Interest Income
    		 27.05M 12.21M 2.57M 137K
    Pretax Income
    		 -160.87M -100.84M -107.49M -71.32M
    Net Income
    		 -160.87M -100.84M -101.08M -68.3M
    Selling & General & Admin
    		 46.58M 36.49M 32.91M 28.01M
    Research & Development
    		 141.3M 97.1M 80.25M 61.36M
    Other Expenses
    		 n/a n/a 2.54M 16K
    Operating Expenses
    		 187.88M 133.59M 113.16M 89.37M
    Interest Expense
    		 n/a n/a n/a n/a
    Selling & Marketing Expenses
    		 n/a n/a n/a n/a
    Cost & Expenses
    		 187.88M 133.59M 113.16M 89.37M
    Income Tax Expense
    		 n/a n/a -6.42M -3.02M
    Shares Outstanding (Basic)
    		 53.94M 39.13M 32.35M 27.73M
    Shares Outstanding (Diluted)
    		 53.94M 39.13M 32.35M 27.73M
    EPS (Basic)
    		 -2.98 -2.58 -3.12 -2.46
    EPS (Diluted)
    		 -2.98 -2.58 -3.12 -2.46
    EBITDA
    		 -187.84M -107.12M -106.15M -68.31M
    EBIT
    		 -187.84M -112.87M -110.03M -71.33M
    Depreciation & Amortization
    		 6.71M 5.75M 3.88M 3.02M

    Add to Watchlist